Historical catalog analysis: CISA added this entry on June 03, 2025. The entry reflects catalog information retrieved on August 31, 2026, not a snapshot archived on the inclusion date. Check current vendor guidance before acting.
What the vulnerability is
CVE-2025-21480 is an incorrect authorization vulnerability affecting multiple Qualcomm chipsets. The flaw exists within the GPU micronode; specifically, a particular sequence of commands can lead to unauthorized command execution, resulting in memory corruption. This vulnerability was added to the CISA Known Exploited Vulnerabilities catalog on June 3, 2025.
Exposure and applicability
This vulnerability is relevant to healthcare organizations that utilize mobile devices, tablets, or specialized medical hardware powered by Qualcomm chipsets. In a clinical environment, these devices are frequently used for accessing electronic Protected Health Information (ePHI), coordinating patient care, and running diagnostic applications. Because the flaw resides at the chipset level, exposure depends on the specific hardware integrated into the device by the Original Equipment Manufacturer (OEM).
Remediation priorities
Our analysis suggests that healthcare security leaders and clinical engineering teams prioritize the following actions to reduce risk:
- Hardware Inventory Audit: Identify all mobile assets and medical devices utilizing Qualcomm-based processors. This is a prerequisite for determining which devices are susceptible.
- OEM Coordination: Contact device manufacturers (OEMs) to verify if their specific hardware models are affected by CVE-2025-21480 and to request the current patching status.
- Patch Deployment: Apply vendor-supplied firmware or software updates as they become available, following established clinical change management protocols to ensure patient care is not interrupted.
- Asset Decommissioning: In cases where a vendor confirms the device is affected but no mitigation or patch is available, evaluate the necessity of the device and consider discontinuing its use in environments handling ePHI.
How to validate remediation
Validation should be conducted through administrative and version-based checks rather than intrusive testing on active medical devices. Organizations can verify remediation by:
* Version Verification: Comparing current firmware versions against the patched versions specified in OEM security advisories.
* Vendor Attestation: Obtaining written confirmation from the device manufacturer that the specific hardware revision or software build addresses CVE-2025-21480.
Limits and open questions
It is currently unknown if this vulnerability has been utilized in ransomware campaigns. Furthermore, because Qualcomm provides chipsets to a vast array of OEMs, there is no single universal patch; remediation is fragmented across different manufacturers. This creates a residual risk where some devices in a fleet may remain vulnerable even after others are updated. Organizations should be aware that while patching reduces the likelihood of exploitation, it does not eliminate all risks associated with hardware-level vulnerabilities.
Source and editorial note
CVE-2025-21480: Qualcomm Multiple Chipsets Incorrect Authorization Vulnerability · Source date: June 03, 2025 · Retrieved August 31, 2026.
Material facts are tied to the cited primary source. Recommendations are independent defensive analysis unless attributed to the source. Confirm consequential decisions against current authoritative guidance.
Archive date: June 06, 2025. The displayed post date is assigned three days after the source date to organize this retrospective archive; it does not mean this site published the analysis then. First published by this site: October 09, 2026 at 01:16 UTC.
Request a healthcare security assessment
Turn healthcare security intelligence into action.
Discuss your environment, priorities, and the evidence needed to validate safeguards.
Request a healthcare assessment ↗